HEADER IMMUNE SYSTEM 06-MAR-14 4PRN TITLE CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-A4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35 ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MHC CLASS I ANTIGEN B*35; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: EPSTEIN-BARR NUCLEAR ANTIGEN 1; COMPND 13 CHAIN: C; COMPND 14 FRAGMENT: UNP RESIDUES 407-417; COMPND 15 SYNONYM: EBNA-1, EBV NUCLEAR ANTIGEN 1; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-B, HLAB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET30; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET30; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: EPSTEIN-BARR VIRUS; SOURCE 24 ORGANISM_COMMON: HHV-4; SOURCE 25 ORGANISM_TAXID: 82830 KEYWDS HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T KEYWDS 2 CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR L.YU CHIH,J.ROSSJOHN,S.GRAS REVDAT 6 20-SEP-23 4PRN 1 REMARK REVDAT 5 22-NOV-17 4PRN 1 REMARK REVDAT 4 02-JUL-14 4PRN 1 JRNL REVDAT 3 18-JUN-14 4PRN 1 JRNL REVDAT 2 23-APR-14 4PRN 1 JRNL REVDAT 1 16-APR-14 4PRN 0 JRNL AUTH Y.C.LIU,Z.CHEN,M.A.NELLER,J.J.MILES,A.W.PURCELL,J.MCCLUSKEY, JRNL AUTH 2 S.R.BURROWS,J.ROSSJOHN,S.GRAS JRNL TITL A MOLECULAR BASIS FOR THE INTERPLAY BETWEEN T CELLS, VIRAL JRNL TITL 2 MUTANTS, AND HUMAN LEUKOCYTE ANTIGEN MICROPOLYMORPHISM. JRNL REF J.BIOL.CHEM. V. 289 16688 2014 JRNL REFN ISSN 0021-9258 JRNL PMID 24759101 JRNL DOI 10.1074/JBC.M114.563502 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.1_743 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.19 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 55688 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 2820 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.1989 - 4.4231 1.00 2913 155 0.1807 0.1982 REMARK 3 2 4.4231 - 3.5120 1.00 2780 149 0.1537 0.1968 REMARK 3 3 3.5120 - 3.0684 1.00 2744 141 0.1807 0.2227 REMARK 3 4 3.0684 - 2.7880 1.00 2731 134 0.1875 0.2338 REMARK 3 5 2.7880 - 2.5883 1.00 2703 156 0.1900 0.2371 REMARK 3 6 2.5883 - 2.4357 1.00 2683 162 0.1927 0.2189 REMARK 3 7 2.4357 - 2.3138 1.00 2679 142 0.1875 0.2224 REMARK 3 8 2.3138 - 2.2131 1.00 2710 145 0.1775 0.1996 REMARK 3 9 2.2131 - 2.1279 1.00 2654 148 0.1797 0.2286 REMARK 3 10 2.1279 - 2.0545 1.00 2701 161 0.1876 0.2277 REMARK 3 11 2.0545 - 1.9902 1.00 2691 133 0.1864 0.2117 REMARK 3 12 1.9902 - 1.9334 1.00 2642 144 0.1909 0.2318 REMARK 3 13 1.9334 - 1.8825 1.00 2649 146 0.1840 0.2287 REMARK 3 14 1.8825 - 1.8365 1.00 2691 150 0.1936 0.2349 REMARK 3 15 1.8365 - 1.7948 1.00 2665 130 0.1980 0.2550 REMARK 3 16 1.7948 - 1.7566 1.00 2694 142 0.2027 0.2311 REMARK 3 17 1.7566 - 1.7215 1.00 2693 124 0.2152 0.2533 REMARK 3 18 1.7215 - 1.6890 1.00 2640 129 0.2307 0.2785 REMARK 3 19 1.6890 - 1.6588 1.00 2663 143 0.2431 0.2883 REMARK 3 20 1.6588 - 1.6307 0.59 1542 86 0.2621 0.3066 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 0.90 REMARK 3 SHRINKAGE RADIUS : 0.61 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 38.95 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.650 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.29 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.47180 REMARK 3 B22 (A**2) : -3.28040 REMARK 3 B33 (A**2) : 5.75230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 3378 REMARK 3 ANGLE : 1.234 4604 REMARK 3 CHIRALITY : 0.087 468 REMARK 3 PLANARITY : 0.005 616 REMARK 3 DIHEDRAL : 13.881 1259 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4PRN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000085135. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.984 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55695 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.7600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.40500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.530 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2FYY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 4000, 0.2M AMMONIUM ACETATE REMARK 280 AND 0.1M NA-CITRATE PH 5.6, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.32000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.55000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.61500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.55000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.32000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.61500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 14 72.47 -158.81 REMARK 500 ASP A 29 -126.27 48.75 REMARK 500 TYR A 123 -60.83 -120.24 REMARK 500 SER A 195 176.58 174.09 REMARK 500 ARG A 239 -22.96 88.74 REMARK 500 LYS B 48 32.81 -88.01 REMARK 500 TRP B 60 -5.63 78.08 REMARK 500 ALA C 6 -167.38 -119.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF EPSTEIN-BARR NUCLEAR REMARK 800 ANTIGEN 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4PR5 RELATED DB: PDB REMARK 900 RELATED ID: 4PRA RELATED DB: PDB REMARK 900 RELATED ID: 4PRB RELATED DB: PDB REMARK 900 RELATED ID: 4PRD RELATED DB: PDB REMARK 900 RELATED ID: 4PRE RELATED DB: PDB REMARK 900 RELATED ID: 4PRH RELATED DB: PDB REMARK 900 RELATED ID: 4PRI RELATED DB: PDB REMARK 900 RELATED ID: 4PRP RELATED DB: PDB DBREF 4PRN A 1 276 UNP P30685 1B35_HUMAN 25 300 DBREF 4PRN B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 4PRN C 1 11 UNP Q1HVF7 EBNA1_EBVA8 407 417 SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE TYR THR ALA MET SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER PRO ARG THR GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP ARG ASN THR GLN SEQRES 6 A 276 ILE PHE LYS THR ASN THR GLN THR TYR ARG GLU SER LEU SEQRES 7 A 276 ARG ASN LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS ILE ILE GLN ARG MET TYR GLY CYS ASP LEU GLY SEQRES 9 A 276 PRO ASP GLY ARG LEU LEU ARG GLY HIS ASP GLN SER ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 276 SER SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE THR SEQRES 12 A 276 GLN ARG LYS TRP GLU ALA ALA ARG VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY LEU CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG ALA SEQRES 15 A 276 ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO VAL SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP ARG THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 11 HIS PRO VAL ALA GLU ALA ASP TYR PHE GLU TYR HET ACT B 101 4 HETNAM ACT ACETATE ION FORMUL 4 ACT C2 H3 O2 1- FORMUL 5 HOH *513(H2 O) HELIX 1 1 ALA A 49 GLU A 53 5 5 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 ARG A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLU A 253 GLN A 255 5 3 HELIX 8 8 ALA C 6 GLU C 10 5 5 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N GLY A 26 O PHE A 33 SHEET 4 A 8 HIS A 3 MET A 12 -1 N ARG A 6 O TYR A 27 SHEET 5 A 8 ILE A 94 LEU A 103 -1 O LEU A 103 N HIS A 3 SHEET 6 A 8 LEU A 109 TYR A 118 -1 O LEU A 110 N ASP A 102 SHEET 7 A 8 LYS A 121 LEU A 126 -1 O LEU A 126 N ASP A 114 SHEET 8 A 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 B 4 LYS A 186 PRO A 193 0 SHEET 2 B 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 B 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 B 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 C 4 LYS A 186 PRO A 193 0 SHEET 2 C 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 C 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 4 GLU A 222 ASP A 223 0 SHEET 2 D 4 THR A 214 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 D 4 TYR A 257 GLN A 262 -1 O HIS A 260 N THR A 216 SHEET 4 D 4 LEU A 270 LEU A 272 -1 O LEU A 272 N CYS A 259 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 O SER B 28 N LYS B 6 SHEET 3 E 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 E 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 F 4 LYS B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 O SER B 28 N LYS B 6 SHEET 3 F 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 F 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 G 4 GLU B 44 ARG B 45 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 G 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 G 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.04 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 CISPEP 1 TYR A 209 PRO A 210 0 1.87 CISPEP 2 HIS B 31 PRO B 32 0 3.43 SITE 1 AC1 4 SER A 92 ASP A 119 ILE B 1 HOH B 276 SITE 1 AC2 33 TYR A 7 ARG A 62 ASN A 63 ILE A 66 SITE 2 AC2 33 PHE A 67 ASN A 70 THR A 73 TYR A 74 SITE 3 AC2 33 GLU A 76 SER A 77 ASN A 80 LEU A 81 SITE 4 AC2 33 TYR A 84 ARG A 97 TYR A 99 SER A 116 SITE 5 AC2 33 THR A 143 LYS A 146 TRP A 147 ALA A 150 SITE 6 AC2 33 GLN A 155 TYR A 159 TRP A 167 TYR A 171 SITE 7 AC2 33 HOH A 326 HOH A 361 HOH C 101 HOH C 102 SITE 8 AC2 33 HOH C 103 HOH C 104 HOH C 105 HOH C 108 SITE 9 AC2 33 HOH C 110 CRYST1 50.640 81.230 109.100 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019747 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012311 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009166 0.00000